Receptors, IgG

"Receptors, IgG" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).

Descriptor ID	D017452
MeSH Number(s)	D12.776.543.750.705.871.300
Concept/Terms	Receptors, IgG Receptors, IgG IgG Receptors gamma Fc Receptors Fc gamma Receptors gamma Receptors, Fc Receptors, Fc gamma Immunoglobulin G Receptor Receptor, Immunoglobulin G Fc Receptors, gamma Receptors, gamma Fc CD32 Antigens CD32 Antigens CD 32 Antigens Antigens, CD 32 Fc gamma RII gamma RII, Fc Antigens, CD32 Leu-11 Antigens Leu-11 Antigens Antigens, Leu-11 Leu 11 Antigens CD64 Antigens CD64 Antigens CD 64 Antigens Antigens, CD 64 Fc gamma RI gamma RI, Fc Antigens, CD64 Antigens, CD16 Antigens, CD16 Fc gamma RIII gamma RIII, Fc CD 16 Antigens Antigens, CD 16 CD16 Antigens CDw32 Antigens CDw32 Antigens Antigens, CDw32

Below are MeSH descriptors whose meaning is more general than "Receptors, IgG".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Membrane Proteins [D12.776.543]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Receptors, Fc [D12.776.543.750.705.871]
Receptors, IgG [D12.776.543.750.705.871.300]

Below are MeSH descriptors whose meaning is related to "Receptors, IgG".

Below are MeSH descriptors whose meaning is more specific than "Receptors, IgG".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, IgG" by people in this website by year, and whether "Receptors, IgG" was a major or minor topic of these publications.

Bar chart showing 23 publications over 12 distinct years, with a maximum of 4 publications in 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
2002	1	0	1
2003	0	3	3
2004	0	2	2
2005	3	1	4
2006	2	1	3
2007	1	1	2
2008	1	0	1
2009	1	0	1
2010	0	3	3
2011	0	1	1
2012	0	1	1

Below are the most recent publications written about "Receptors, IgG" by people in Profiles.

Trotta R, Chen L, Ciarlariello D, Josyula S, Mao C, Costinean S, Yu L, Butchar JP, Tridandapani S, Croce CM, Caligiuri MA. miR-155 regulates IFN-? production in natural killer cells. Blood. 2012 Apr 12; 119(15):3478-85.

View in: PubMed
Stolla M, Stefanini L, André P, Ouellette TD, Reilly MP, McKenzie SE, Bergmeier W. CalDAG-GEFI deficiency protects mice in a novel model of Fc? RIIA-mediated thrombosis and thrombocytopenia. Blood. 2011 Jul 28; 118(4):1113-20.

View in: PubMed
Baiocchi RA, Alinari L, Lustberg ME, Lin TS, Porcu P, Li X, Johnston JS, Byrd JC, Blum KA. Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma. Cancer. 2011 Jun 01; 117(11):2442-51.

View in: PubMed
Reilly MP, Sinha U, André P, Taylor SM, Pak Y, Deguzman FR, Nanda N, Pandey A, Stolla M, Bergmeier W, McKenzie SE. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. Blood. 2011 Feb 17; 117(7):2241-6.

View in: PubMed
Crow AR, Song S, Suppa SJ, Ma S, Reilly MP, Andre P, McKenzie SE, Lazarus AH. Amelioration of murine immune thrombocytopenia by CD44 antibodies: a potential therapy for ITP? Blood. 2011 Jan 20; 117(3):971-4.

View in: PubMed
Flores M, Desai DD, Downie M, Liang B, Reilly MP, McKenzie SE, Clynes R. Dominant expression of the inhibitory FcgammaRIIB prevents antigen presentation by murine plasmacytoid dendritic cells. J Immunol. 2009 Dec 1; 183(11):7129-39.

View in: PubMed
Trotta R, Dal Col J, Yu J, Ciarlariello D, Thomas B, Zhang X, Allard J, Wei M, Mao H, Byrd JC, Perrotti D, Caligiuri MA. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. J Immunol. 2008 Sep 15; 181(6):3784-92.

View in: PubMed
Schirmer DA, Song SC, Baliff JP, Harbers SO, Clynes RA, Krop-Watorek A, Halverson GR, Czerwinski M, Spitalnik SL. Mouse models of IgG- and IgM-mediated hemolysis. Blood. 2007 Apr 1; 109(7):3099-107.

View in: PubMed
Rahman ZS, Alabyev B, Manser T. FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity. J Immunol. 2007 Jan 15; 178(2):897-907.

View in: PubMed
Khan KD, Emmanouilides C, Benson DM, Hurst D, Garcia P, Michelson G, Milan S, Ferketich AK, Piro L, Leonard JP, Porcu P, Eisenbeis CF, Banks AL, Chen L, Byrd JC, Caligiuri MA. A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma. Clin Cancer Res. 2006 Dec 01; 12(23):7046-53.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement